Confirming racial/ethnic disparities in the management of severe bronchiolitis

In addition to race/ethnicity, models were adjusted for age, sex, estimated median household income (MHI) per ZIP code [11], clinically relevant covariates, and potential clustering by site. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.Conflict of interest The authors report no conflicts of interest relevant to this work.Author contributions statement DXZ and RG conceived the study. Non-Hispanic White (n = 430) Non-Hispanic Black (n = 239) Hispanic (n = 308) Odds Ratio (95% Confidence Interval) Pre-admission interventions Chest X-ray⁎ 1.00 (reference) 1.04 (0.68–1.58) 1.03 (0.75–1.42) Albuterol use† 1.00 (reference) 1.11 (0.78–1.57) 1.19 (0.49–2.89) Corticosteroid use‡ 1.00 (reference) 1.55 (0.73–3.29) 1.31 (0.72–2.39) Inpatient interventions Chest X-ray§ 1.00 (reference) 0.64 (0.45–0.93) 0.77 (0.49–1.22) Albuterol use‖ 1.00 (reference) 1.83 (1.27–2.63) 1.65 (1.05–2.59) Corticosteroid use¶ 1.00 (reference) 1.50 (0.60–3.71) 1.76 (0.91–3.41) Intensive care interventions⁎⁎ 1.00 (reference) 0.93 (0.63–1.37) 1.53 (0.87–2.69) Length-of-stay ≥3 days†† 1.00 (reference) 0.76 (0.41–1.41) 0.68 (0.40–1.14) Discharge & short-term follow-up Discharged on corticosteroids 1.00 (reference) 2.12 (0.89–5.07) 1.91 (1.05–3.48) Bronchiolitis relapse‡‡ 1.00 (reference) 1.09 (0.68–1.75) 1.27 (0.67–2.39) Table 2 Multivariable results for race/ethnicity and clinical outcomes among U.S. infants hospitalized for bronchiolitis